Jeil Pharmaceutical Co.,Ltd
KRX:271980.KS
15180 (KRW) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 32,990.886 | 31,446.234 | 25,963.279 | 3,893.474 | 13,515.271 | 2,495.34 | 16,208.242 | 30,078.663 | 13,538.06 |
Short Term Investments
| 2,666.657 | 142.458 | 2,040.062 | 2,694.588 | 4.762 | 350 | 0 | 3,093.031 | 3,049.06 |
Cash and Short Term Investments
| 35,657.543 | 31,588.692 | 28,003.341 | 6,588.062 | 13,520.033 | 2,845.34 | 16,208.242 | 33,171.694 | 16,587.12 |
Net Receivables
| 166,225.495 | 156,369.809 | 148,995.065 | 157,322.929 | 162,325.271 | 182,064.555 | 198,701.454 | 196,716.87 | 198,160.584 |
Inventory
| 109,768.045 | 99,150.809 | 102,457.666 | 109,310.619 | 84,071.452 | 88,446.066 | 83,692.886 | 80,452.47 | 73,623.242 |
Other Current Assets
| 5,394.839 | 4,531.477 | 5,216.254 | 4,291.208 | 4,217.438 | 0.001 | 0.001 | 2,408.772 | 823.22 |
Total Current Assets
| 317,045.923 | 291,640.788 | 284,672.326 | 277,512.818 | 264,134.194 | 273,355.962 | 298,602.582 | 312,749.806 | 289,194.166 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 137,040.757 | 138,402.417 | 125,709.643 | 115,547.198 | 121,614.302 | 120,481.184 | 102,658.484 | 115,159.754 | 92,082.516 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 12,880.971 | 9,381.751 | 3,762.338 | 4,095.369 | 4,323.894 | 4,359.053 | 4,090.269 | 0 | 0 |
Goodwill and Intangible Assets
| 12,880.971 | 9,381.751 | 3,762.338 | 4,095.369 | 4,323.894 | 4,359.053 | 4,090.269 | 0 | 0 |
Long Term Investments
| 11,725.659 | 9,250.756 | 2,992.114 | -774.939 | 923.937 | 627.948 | 3,025.04 | 57,415.596 | 56,364.278 |
Tax Assets
| 5,359.488 | 172.387 | 1,451.505 | 3,321.251 | 2,359.711 | 944.392 | 2,005.394 | 0 | 0 |
Other Non-Current Assets
| 3,273.5 | 8,043.441 | 7,898.492 | 9,961.601 | 8,229.082 | 3,134.583 | 3,344.333 | 6,659.841 | 7,525.146 |
Total Non-Current Assets
| 170,280.375 | 165,250.752 | 141,814.092 | 132,150.48 | 137,450.925 | 129,547.161 | 115,123.52 | 179,235.191 | 155,971.94 |
Total Assets
| 487,326.298 | 456,891.539 | 426,486.418 | 409,663.297 | 401,585.119 | 402,903.123 | 413,726.102 | 491,984.997 | 445,166.106 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 144,338.12 | 151,641.431 | 153,084.038 | 143,363.086 | 149,575.963 | 144,752.774 | 146,726.744 | 140,161.244 | 129,398.469 |
Short Term Debt
| 80,513.608 | 44,908.02 | 32,205.798 | 38,141.813 | 14,005.963 | 17,973.333 | 36,314.628 | 29,457.797 | 21,345.475 |
Tax Payables
| 448.245 | 1,049.118 | 114.569 | 3,432.299 | 4,244.549 | 1,359.656 | 2,080.071 | 2,647.093 | 4,839.684 |
Deferred Revenue
| 1,733.818 | 1,650.242 | 21,355.614 | 23,440.143 | 32,260.568 | 1,359.656 | 23,415.585 | 678.34 | 331.751 |
Other Current Liabilities
| 91,584.911 | 70,457.445 | 15,297.732 | 13,113.228 | 12,676.784 | 30,470.334 | -0 | 23,256.958 | 23,954.287 |
Total Current Liabilities
| 318,170.458 | 268,657.137 | 221,943.181 | 218,058.27 | 208,519.278 | 194,556.097 | 206,456.956 | 193,554.339 | 175,029.982 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 4,452.004 | 5,442.568 | 8,148.622 | 11,162.515 | 18,417.644 | 19,906.25 | 25,500 | 27,500 | 5,000 |
Deferred Revenue Non-Current
| 200.011 | 227.111 | 248.111 | 379.419 | 346.111 | 257.111 | 0 | -0 | 0 |
Deferred Tax Liabilities Non-Current
| -200.011 | 0 | 28,799.305 | 7,583.805 | 4,257.802 | 3,249.12 | 0 | 6,305.348 | 7,285.499 |
Other Non-Current Liabilities
| 7,671.664 | 26,967.503 | 0.001 | 0.001 | -0 | -0 | 3,782.909 | 12,545.581 | 16,462.17 |
Total Non-Current Liabilities
| 12,123.668 | 32,637.182 | 37,196.039 | 19,125.74 | 23,021.557 | 23,412.481 | 29,282.909 | 46,350.929 | 28,747.669 |
Total Liabilities
| 330,294.126 | 301,294.32 | 259,139.22 | 237,184.01 | 231,540.836 | 217,968.578 | 235,739.865 | 239,905.268 | 203,777.651 |
Equity: | |||||||||
Preferred Stock
| 13,795.335 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 7,352.436 | 7,352.436 | 7,352.436 | 7,352.436 | 7,352.436 | 7,352.436 | 5,252.247 | 7,425 | 7,425 |
Retained Earnings
| -20,193.116 | -20,320.91 | -10,413.554 | 2,840.808 | 5,216.066 | 18,850.557 | 1,751.92 | 227,629.913 | 221,628.282 |
Accumulated Other Comprehensive Income/Loss
| 20,943.279 | 20,870.421 | 20,775.621 | 16,969.532 | 17,035.24 | 9,928.224 | 0 | 20,103.918 | 20,414.129 |
Other Total Stockholders Equity
| 136,672.186 | 150,007.074 | 150,498.857 | 145,231.468 | 140,440.543 | 148,803.328 | 170,982.071 | -6,218.277 | -8,078.956 |
Total Shareholders Equity
| 158,570.12 | 157,909.021 | 168,213.36 | 172,394.244 | 170,044.284 | 184,934.545 | 177,986.237 | 248,940.553 | 241,388.455 |
Total Equity
| 157,032.172 | 155,597.22 | 167,347.198 | 172,479.288 | 170,044.284 | 184,934.545 | 177,986.237 | 252,079.729 | 241,388.455 |
Total Liabilities & Shareholders Equity
| 487,326.298 | 456,891.539 | 426,486.418 | 409,663.297 | 401,585.119 | 402,903.123 | 413,726.102 | 491,984.997 | 445,166.106 |